Annual Current Assets
$1.46 M
+$420.00 K+40.50%
31 December 2022
Summary:
Nymox Pharmaceutical annual total current assets is currently $1.46 million, with the most recent change of +$420.00 thousand (+40.50%) on 31 December 2022. During the last 3 years, it has fallen by -$2.44 million (-62.57%).NYMX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$461.00 K
-$996.00 K-68.36%
31 March 2023
Summary:
Nymox Pharmaceutical quarterly total current assets is currently $461.00 thousand, with the most recent change of -$996.00 thousand (-68.36%) on 31 March 2023.NYMX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -62.6% | -86.4% |
| 5 y5 years | -81.8% | -93.6% |
NYMX Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -89.2% | -96.6% |
Nymox Pharmaceutical Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $461.00 K(-68.4%) |
| Dec 2022 | $168.00 K(-58.6%) | $1.46 M(-49.9%) |
| Sept 2022 | - | $2.91 M(-30.4%) |
| June 2022 | - | $4.18 M(+370.2%) |
| Mar 2022 | - | $890.00 K(-14.2%) |
| Dec 2021 | $406.00 K(-9.8%) | $1.04 M(-69.4%) |
| Sept 2021 | - | $3.39 M(-46.5%) |
| June 2021 | - | $6.33 M(+497.1%) |
| Mar 2021 | - | $1.06 M(-72.7%) |
| Dec 2020 | $450.00 K(+181.3%) | $3.89 M(-30.9%) |
| Sept 2020 | - | $5.63 M(+535.8%) |
| June 2020 | - | $886.00 K(-71.7%) |
| Mar 2020 | - | $3.13 M(-41.2%) |
| Dec 2019 | $160.00 K(+220.0%) | $5.33 M(-26.2%) |
| Sept 2019 | - | $7.22 M(-21.6%) |
| June 2019 | - | $9.20 M(-19.4%) |
| Mar 2019 | - | $11.42 M(+42.3%) |
| Dec 2018 | $50.00 K(+194.1%) | $8.03 M(+68.9%) |
| Sept 2018 | - | $4.75 M(-7.7%) |
| June 2018 | - | $5.15 M(+450.0%) |
| Mar 2018 | - | $936.00 K(-2.6%) |
| Dec 2017 | $17.00 K(-10.5%) | $961.00 K(-46.1%) |
| Sept 2017 | - | $1.78 M(+36.7%) |
| June 2017 | - | $1.30 M(-22.7%) |
| Mar 2017 | - | $1.69 M(-17.2%) |
| Dec 2016 | $19.00 K(-5.0%) | $2.04 M(+25.5%) |
| Sept 2016 | - | $1.62 M(+322.4%) |
| June 2016 | - | $384.60 K(-62.1%) |
| Mar 2016 | - | $1.02 M(+46.7%) |
| Dec 2015 | $20.00 K(-25.4%) | $692.00 K(+6.9%) |
| Sept 2015 | - | $647.20 K(-48.8%) |
| June 2015 | - | $1.26 M(+55.7%) |
| Mar 2015 | - | $811.10 K(-41.9%) |
| Dec 2014 | $26.80 K(-10.4%) | $1.40 M(+51.1%) |
| Sept 2014 | - | $923.70 K(+21.7%) |
| June 2014 | - | $759.30 K(-10.5%) |
| Mar 2014 | - | $848.50 K(-9.4%) |
| Dec 2013 | $29.90 K(+98.0%) | $936.50 K(-9.7%) |
| Sept 2013 | - | $1.04 M(-23.0%) |
| June 2013 | - | $1.35 M(-40.5%) |
| Mar 2013 | - | $2.27 M(+30.3%) |
| Dec 2012 | $15.10 K(-61.9%) | $1.74 M(-17.9%) |
| Sept 2012 | - | $2.12 M(-21.1%) |
| June 2012 | - | $2.69 M(-27.0%) |
| Mar 2012 | - | $3.68 M(-41.9%) |
| Dec 2011 | $39.60 K(+23.4%) | $6.34 M(-2.2%) |
| Sept 2011 | - | $6.48 M(-13.9%) |
| June 2011 | - | $7.53 M(-24.6%) |
| Mar 2011 | - | $9.98 M(-25.9%) |
| Dec 2010 | $32.10 K | $13.47 M(+1491.8%) |
| Sept 2010 | - | $846.20 K(+5.2%) |
| June 2010 | - | $804.70 K(-27.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $1.11 M(+3.3%) |
| Dec 2009 | $16.20 K(-94.0%) | $1.07 M(-22.9%) |
| Sept 2009 | - | $1.39 M(+48.7%) |
| June 2009 | - | $936.40 K(+47.2%) |
| Mar 2009 | - | $636.20 K(+32.4%) |
| Dec 2008 | $269.40 K(-93.0%) | $480.50 K(-14.4%) |
| Sept 2008 | - | $561.20 K(+17.8%) |
| June 2008 | - | $476.30 K(-29.4%) |
| Mar 2008 | - | $675.00 K(+56.6%) |
| Dec 2007 | $3.83 M(+6.6%) | $431.00 K(-12.3%) |
| Sept 2007 | - | $491.50 K(-57.6%) |
| June 2007 | - | $1.16 M(+60.4%) |
| Mar 2007 | - | $723.40 K(+90.8%) |
| Dec 2006 | $3.59 M(+4.8%) | $379.20 K(+19.2%) |
| Sept 2006 | - | $318.10 K(+49.6%) |
| June 2006 | - | $212.60 K(-80.8%) |
| Mar 2006 | - | $1.11 M(+280.7%) |
| Dec 2005 | $3.43 M(+1.8%) | $291.50 K(-21.8%) |
| Sept 2005 | - | $372.70 K(+27.8%) |
| June 2005 | - | $291.70 K(-2.8%) |
| Mar 2005 | - | $300.10 K(-57.1%) |
| Dec 2004 | $3.37 M(+3.4%) | $699.10 K(+37.2%) |
| Sept 2004 | - | $509.50 K(-4.8%) |
| June 2004 | - | $535.00 K(+3.2%) |
| Mar 2004 | - | $518.40 K(-30.7%) |
| Dec 2003 | $3.26 M(-6.9%) | $747.70 K(-20.2%) |
| Sept 2003 | - | $936.70 K(+144.8%) |
| June 2003 | - | $382.70 K(-58.0%) |
| Mar 2003 | - | $911.20 K(+5.7%) |
| Dec 2002 | $3.50 M(+0.5%) | $862.40 K(+39.0%) |
| Sept 2002 | - | $620.60 K(-26.7%) |
| June 2002 | - | $847.00 K(-34.7%) |
| Mar 2002 | - | $1.30 M(+81.6%) |
| Dec 2001 | $3.48 M(-4.3%) | $714.50 K(-23.4%) |
| Sept 2001 | - | $933.20 K(+38.9%) |
| June 2001 | - | $671.90 K(-10.9%) |
| Mar 2001 | - | $754.30 K(+0.6%) |
| Dec 2000 | $3.64 M(+166.6%) | $749.50 K(-33.5%) |
| Sept 2000 | - | $1.13 M(-38.2%) |
| June 2000 | - | $1.82 M(-43.7%) |
| Mar 2000 | - | $3.24 M(+317.2%) |
| Dec 1999 | $1.36 M(+6.6%) | $776.80 K(-35.2%) |
| Sept 1999 | - | $1.20 M(-19.7%) |
| June 1999 | - | $1.49 M(-17.1%) |
| Mar 1999 | - | $1.80 M(-33.5%) |
| Dec 1998 | $1.28 M(+60.1%) | $2.71 M(+0.1%) |
| Sept 1998 | - | $2.71 M(-35.6%) |
| June 1998 | - | $4.20 M(+50.2%) |
| Mar 1998 | - | $2.80 M(+64.7%) |
| Dec 1997 | $799.20 K | $1.70 M(-22.8%) |
| Sept 1997 | - | $2.20 M(-35.3%) |
| June 1997 | - | $3.40 M |
FAQ
- What is Nymox Pharmaceutical annual total current assets?
- What is the all time high annual current assets for Nymox Pharmaceutical?
- What is Nymox Pharmaceutical quarterly total current assets?
- What is the all time high quarterly current assets for Nymox Pharmaceutical?
What is Nymox Pharmaceutical annual total current assets?
The current annual current assets of NYMX is $1.46 M
What is the all time high annual current assets for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual total current assets is $13.47 M
What is Nymox Pharmaceutical quarterly total current assets?
The current quarterly current assets of NYMX is $461.00 K
What is the all time high quarterly current assets for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly total current assets is $13.47 M